Your browser doesn't support javascript.
loading
Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region.
Fairhurst, Robin A; Knoepfel, Thomas; Leblanc, Catherine; Buschmann, Nicole; Gaul, Christoph; Blank, Jutta; Galuba, Inga; Trappe, Jörg; Zou, Chao; Voshol, Johannes; Genick, Christine; Brunet-Lefeuvre, Peggy; Bitsch, Francis; Graus-Porta, Diana; Furet, Pascal.
Afiliación
  • Fairhurst RA; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Knoepfel T; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Leblanc C; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Buschmann N; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Gaul C; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Blank J; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Galuba I; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Trappe J; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Zou C; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Voshol J; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Genick C; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Brunet-Lefeuvre P; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Bitsch F; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Graus-Porta D; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
  • Furet P; Novartis Institutes for BioMedical Research , CH-4002 Basel , Switzerland . Email: robin.fairhurst@novartis.com.
Medchemcomm ; 8(8): 1604-1613, 2017 Aug 01.
Article en En | MEDLINE | ID: mdl-30108871

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Medchemcomm Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Medchemcomm Año: 2017 Tipo del documento: Article